| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Potter Stephen W | Chief Business Officer | Jul 01, 2022 | Sale | $0.77 | 8,070 | 6,250 | 55,883 | Jul 01, 2022, 04:01 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Reynolds Gerald Anthony | Chief Accounting Officer | May 27, 2022 | Sale | $0.85 | 3,994 | 3,376 | 21,006 | May 31, 2022, 04:24 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Washer Susan B. | President and CEO | Feb 18, 2022 | Option Exercise | $0.49 | 130,636 | 63,931 | 152,971 | Feb 22, 2022, 09:34 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Washer Susan B. | President and CEO | Nov 01, 2021 | Option Exercise | $3.50 | 3,877 | 13,570 | 32,285 | Nov 03, 2021, 07:19 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Potter Stephen W | Chief Business Officer | Aug 15, 2021 | Option Exercise | $3.58 | 5,724 | 20,492 | 63,953 | Aug 17, 2021, 06:42 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Potter Stephen W | VP and Chief Business Officer | Aug 15, 2020 | Option Exercise | $5.77 | 5,723 | 33,022 | 34,677 | Aug 18, 2020, 06:22 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Shearman Mark S | Chief Scientific Officer | Aug 15, 2020 | Option Exercise | $5.77 | 5,723 | 33,022 | 33,277 | Aug 18, 2020, 06:15 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Inspirational Visions B.V. | 10% Owner | Dec 26, 2019 | Sale | $5.24 | 81,162 | 425,289 | 1,780,762 | Dec 30, 2019, 04:33 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Inspirational Visions B.V. | 10% Owner | Nov 19, 2019 | Buy | $2.79 | 2,544 | 7,098 | 1,861,924 | Nov 26, 2019, 05:17 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Washer Susan B. | President and CEO | Sep 18, 2019 | Option Exercise | $3.50 | 5,700 | 19,950 | 28,408 | Sep 20, 2019, 04:22 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Feinsod Matthew | Interim Chief Medical Officer | Jul 11, 2019 | Option Exercise | $3.75 | 592 | 2,220 | 56,052 | Jul 15, 2019, 04:45 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Feinsod Matthew | Interim Chief Medical Officer | Jun 11, 2019 | Option Exercise | $3.70 | 685 | 2,535 | 54,644 | Jun 20, 2019, 04:39 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Feinsod Matthew | Interim Chief Medical Officer | Jun 11, 2019 | Option Exercise | $3.77 | 685 | 2,582 | 54,644 | Jun 13, 2019, 07:21 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Koenig Scott | Director | May 28, 2019 | Option Exercise | $0.35 | 32,018 | 11,206 | 34,246 | May 30, 2019, 04:04 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Feinsod Matthew | Interim Chief Medical Officer | May 13, 2019 | Option Exercise | $4.06 | 685 | 2,781 | 53,329 | May 20, 2019, 04:02 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Feinsod Matthew | Interim Chief Medical Officer | May 13, 2019 | Option Exercise | $4.20 | 685 | 2,877 | 53,329 | May 15, 2019, 04:21 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Feinsod Matthew | Interim Chief Medical Officer | Apr 11, 2019 | Option Exercise | $4.61 | 606 | 2,794 | 52,014 | Apr 15, 2019, 05:42 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Feinsod Matthew | Interim Chief Medical Officer | Mar 11, 2019 | Option Exercise | $3.97 | 667 | 2,648 | 50,620 | Mar 13, 2019, 05:16 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Feinsod Matthew | Interim Chief Medical Officer | Feb 11, 2019 | Option Exercise | $3.29 | 791 | 2,602 | 49,287 | Feb 13, 2019, 06:30 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Feinsod Matthew | Interim Chief Medical Officer | Jan 11, 2019 | Option Exercise | $3.20 | 713 | 2,282 | 48,078 | Jan 15, 2019, 07:58 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Rosen James | Director | Dec 14, 2018 | Buy | $3.38 | 1,000 | 3,381 | 1,000 | Dec 18, 2018, 08:29 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Aliski William | Director | Dec 14, 2018 | Buy | $3.25 | 6,000 | 19,477 | 8,500 | Dec 18, 2018, 08:20 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Sullivan William A. | Chief Financial Officer | Dec 14, 2018 | Buy | $3.33 | 3,000 | 9,990 | 3,000 | Dec 18, 2018, 08:10 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Shearman Mark S | Chief Scientific Officer | Dec 14, 2018 | Sale | $3.35 | 3,000 | 10,053 | 0 | Dec 18, 2018, 07:58 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Washer Susan B. | President and CEO | Dec 14, 2018 | Buy | $3.34 | 2,380 | 7,949 | 22,708 | Dec 18, 2018, 07:36 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Feinsod Matthew | Interim Chief Medical Officer | Dec 11, 2018 | Option Exercise | $6.11 | 611 | 3,733 | 46,791 | Dec 13, 2018, 09:23 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Feinsod Matthew | Interim Chief Medical Officer | Nov 12, 2018 | Option Exercise | $7.05 | 685 | 4,829 | 45,402 | Nov 14, 2018, 04:43 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Feinsod Matthew | Interim Chief Medical Officer | Oct 11, 2018 | Option Exercise | $6.46 | 612 | 3,954 | 44,087 | Oct 15, 2018, 07:01 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Feinsod Matthew | Interim Chief Medical Officer | Sep 11, 2018 | Option Exercise | $3.92 | 685 | 2,689 | 42,699 | Sep 13, 2018, 05:04 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Feinsod Matthew | Interim Chief Medical Officer | Aug 13, 2018 | Option Exercise | $4.00 | 592 | 2,368 | 41,384 | Aug 15, 2018, 07:07 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Feinsod Matthew | Interim Chief Medical Officer | Jul 11, 2018 | Option Exercise | $4.15 | 685 | 2,843 | 39,976 | Jul 13, 2018, 05:57 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Feinsod Matthew | Interim Chief Medical Officer | Jun 11, 2018 | Option Exercise | $4.55 | 606 | 2,757 | 38,661 | Jun 13, 2018, 07:33 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Feinsod Matthew | Interim Chief Medical Officer | May 16, 2018 | Option Exercise | $5.60 | 3,425 | 19,180 | 37,267 | May 18, 2018, 06:17 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Feinsod Matthew | Interim Chief Medical Officer | May 11, 2018 | Option Exercise | $4.90 | 685 | 3,357 | 40,692 | May 15, 2018, 04:34 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Feinsod Matthew | Interim Chief Medical Officer | Apr 11, 2018 | Option Exercise | $4.00 | 685 | 2,740 | 39,377 | Apr 13, 2018, 04:20 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Feinsod Matthew | Interim Chief Medical Officer | Feb 09, 2018 | Option Exercise | $3.95 | 733 | 2,895 | 26,729 | Apr 06, 2018, 08:45 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Feinsod Matthew | Interim Chief Medical Officer | Jan 11, 2018 | Option Exercise | $4.30 | 791 | 3,401 | 25,462 | Apr 06, 2018, 08:26 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Feinsod Matthew | Interim Chief Medical Officer | Dec 11, 2017 | Option Exercise | $3.75 | 3,395 | 12,731 | 24,253 | Apr 06, 2018, 08:15 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Feinsod Matthew | Interim Chief Medical Officer | Mar 12, 2018 | Option Exercise | $4.30 | 667 | 2,868 | 32,126 | Mar 14, 2018, 07:49 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Feinsod Matthew | Interim Chief Medical Officer | Jan 11, 2018 | Option Exercise | $4.30 | 855 | 3,677 | 28,793 | Jan 16, 2018, 08:29 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Magovcevic Ivana | Director | Nov 16, 2016 | Buy | $9.63 | 3,000 | 28,875 | 3,000 | Nov 17, 2016, 04:53 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Chulay Jeffrey D. | VP and Chief Medical Officer | Nov 01, 2016 | Sale | $7.05 | 1,000 | 7,051 | 20,400 | Nov 02, 2016, 06:42 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Chulay Jeffrey D. | VP and Chief Medical Officer | Oct 19, 2016 | Option Exercise | $0.35 | 10,000 | 3,500 | 21,400 | Oct 27, 2016, 08:24 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Chulay Jeffrey D. | VP and Chief Medical Officer | Oct 19, 2016 | Option Exercise | $0.35 | 1,000 | 350 | 12,400 | Oct 21, 2016, 06:03 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Potter Stephen W | See Remarks | Sep 16, 2016 | Buy | $8.97 | 1,000 | 8,970 | 1,000 | Sep 27, 2016, 05:12 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Potter Stephen W | See Remarks | Sep 20, 2016 | Buy | $8.69 | 400 | 3,476 | 1,400 | Sep 27, 2016, 05:12 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Shearman Mark S | Chief Scientific Officer | Sep 22, 2016 | Buy | $8.87 | 3,000 | 26,601 | 3,000 | Sep 26, 2016, 05:20 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | BULLOCK LAWRENCE E | Chief Financial Officer | Sep 19, 2016 | Buy | $8.75 | 10,000 | 87,500 | 10,000 | Sep 20, 2016, 04:51 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Washer Susan B. | See Remarks | Aug 29, 2016 | Option Exercise | $3.50 | 5,328 | 18,648 | 20,328 | Aug 30, 2016, 05:43 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Chulay Jeffrey D. | VP and Chief Medical Officer | May 25, 2016 | Option Exercise | $3.50 | 2,000 | 7,000 | 11,900 | May 26, 2016, 07:03 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Chulay Jeffrey D. | VP and Chief Medical Officer | May 11, 2016 | Option Exercise | $3.50 | 4,000 | 14,000 | 9,900 | May 26, 2016, 07:00 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | GLAXOSMITHKLINE PLC | Former 10% Owner | Feb 23, 2015 | Sale | $22.00 | 503,150 | 11,069,602 | 1,436,448 | Feb 24, 2015, 04:05 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | GLAXOSMITHKLINE PLC | 10% Owner | Dec 18, 2014 | Sale | $21.01 | 12,000 | 252,136 | 1,939,598 | Feb 12, 2015, 06:31 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | GLAXOSMITHKLINE PLC | 10% Owner | Dec 10, 2014 | Sale | $21.18 | 10,000 | 211,760 | 1,979,598 | Feb 12, 2015, 06:31 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | GLAXOSMITHKLINE PLC | 10% Owner | Dec 11, 2014 | Sale | $21.28 | 12,500 | 266,035 | 1,967,098 | Feb 12, 2015, 06:31 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | GLAXOSMITHKLINE PLC | 10% Owner | Dec 12, 2014 | Sale | $21.24 | 7,500 | 159,294 | 1,959,598 | Feb 12, 2015, 06:31 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | GLAXOSMITHKLINE PLC | 10% Owner | Dec 17, 2014 | Sale | $21.00 | 8,000 | 168,000 | 1,951,598 | Feb 12, 2015, 06:31 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Menichella Daniel L | V.P. & Chief Business Officer | Jan 23, 2015 | Option Exercise | $14.90 | 3,992 | 59,481 | 1,996 | Jan 26, 2015, 06:04 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Menichella Daniel L | V.P. & Chief Business Officer | Dec 22, 2014 | Option Exercise | $12.87 | 18,000 | 231,570 | 9,000 | Dec 23, 2014, 02:54 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | GLAXOSMITHKLINE PLC | 10% Owner | Apr 01, 2014 | Buy | $12.00 | 103,762 | 1,245,144 | 1,989,598 | Apr 02, 2014, 12:42 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Wu Samuel | Director | Apr 01, 2014 | Buy | $12.00 | 75,735 | 908,820 | 1,452,196 | Apr 01, 2014, 04:31 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Rosen James | Director | Apr 01, 2014 | Buy | $12.00 | 62,871 | 754,452 | 1,205,537 | Apr 01, 2014, 04:31 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | ORONSKY ARNOLD L | Director | Apr 01, 2014 | Buy | $12.00 | 75,736 | 908,832 | 1,452,216 | Apr 01, 2014, 04:30 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | MedImmune Ventures, Inc. | 10% Owner | Apr 01, 2014 | Buy | $12.00 | 75,735 | 908,820 | 1,452,196 | Apr 01, 2014, 04:29 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Carroll Jill | Director | Apr 01, 2014 | Buy | $12.00 | 103,762 | 1,245,144 | 1,989,598 | Apr 01, 2014, 04:29 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | NOHRA GUY P | 10% Owner | Apr 01, 2014 | Buy | $12.00 | 155,645 | 1,867,740 | 2,984,400 | Apr 01, 2014, 04:28 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | CASH HARVEY B | 10% Owner | Apr 01, 2014 | Buy | $12.00 | 75,376 | 904,512 | 1,452,216 | Apr 01, 2014, 02:06 PM |
Menu